SCHEMBL26416179

SCHEMBL26416179

c1ccc(-c2cc(-c3ccccc3)nc(-c3cc(-c4ccc(-c5ccc6ccccc6c5)cc4)cc4c3oc3cc5ccccc5cc34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ CYP1A2 P05177 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ TP53 P04637 3/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ CYP2C19 P33261 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ CTRC Q99895 1/20 0.36
▸ PGR P06401 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ NTSR1 P30989 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ESR1 P03372 3/20 0.34
▸ ESR2 Q92731 3/20 0.34
▸ CYP17A1 P05093 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24586404 0.92 ALDH1A1 (0.41) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL24586425 0.89 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL24586426 0.89 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL24585757 0.89 ALDH1A1 (0.41) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL24585756 0.89 ALDH1A1 (0.41) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL24585758 0.89 KMT2A (0.38) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL25855101 0.89 ESR1 (0.36) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL24066237 0.88 ALDH1A1 (0.39) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL26571949 0.88 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2KMT2ATP53
SCHEMBL24066229 0.88 MEN1 (0.42) CYP1A1CYP1B1CYP1A2KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 — — US disclosed
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 CYP1A1 4/4885CYP1B1 6/4885CYP1A2 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback